Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension [11]

Heart

Volumn 92, Issue 8, 2006, Pages 1164-1166

  Barbaro, Giuseppe ^a,f   Lucchini, A ^b   Pellicelli, A M ^c   Grisorio, B ^d   Giancaspro, G ^a   Barbarini, G ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ALT ONLUS   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d GENERAL HOSPITAL   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; BOSENTAN; DIDANOSINE; EFAVIRENZ; INDINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; ZIDOVUDINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LETTER; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SIDE EFFECT;

ADULT; ANTIHYPERTENSIVE AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG COMBINATIONS; EXERCISE TEST; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SULFONAMIDES; TREATMENT OUTCOME;

EID: 33746431294     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.076794     Document Type: Letter

References (5)

1. Zuber JP, Calmy A, Evison JM, et al. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004;38:1178-85.
2. Channick RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 2001;358:1119-23.
3. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903.
4. Sitbon O, Gressin V, Speich R, et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care 2004;170:1212-7.
5. Aguilar RV, Farber HW. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care 2000;162:1846-50.